Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Daratumumab plus lenalidomide/dexamethasone in untreated multiple myeloma: analysis of key subgroups of the MAIA study.
Moreau P, Facon T, Usmani SZ, Bahlis N, Raje N, Plesner T, Orlowski RZ, Basu S, Nahi H, Hulin C, Quach H, Goldschmidt H, O'Dwyer M, Perrot A, Venner CP, Weisel K, Tiab M, Macro M, Frenzel L, Leleu X, Wang G, Pei H, Krevvata M, Carson R, Borgsten F, Kumar SK. Moreau P, et al. Among authors: plesner t. Leukemia. 2025 Jan 15. doi: 10.1038/s41375-024-02506-1. Online ahead of print. Leukemia. 2025. PMID: 39815052
Differential tumor protein expression at follicular lymphoma diagnosis reveals dysregulation of key molecular pathways associated with histological transformation.
Enemark MH, Wolter K, Hybel TE, Andersen MD, Sørensen EF, Hindkaer LM, Lauridsen KL, Madsen C, Plesner TL, Hamilton-Dutoit S, Honoré B, Ludvigsen M. Enemark MH, et al. Among authors: plesner tl. Sci Rep. 2024 Dec 2;14(1):29962. doi: 10.1038/s41598-024-81693-4. Sci Rep. 2024. PMID: 39622932 Free PMC article.
Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohort.
Enemark MH, Hemmingsen JK, Andersen MD, Hybel TE, Bjørn ME, Josefsson PL, Pedersen LM, Juul MB, Pedersen RS, Thorsgaard M, Sillesen IB, Plesner TL, Hamilton-Dutoit SJ, Jensen P, Madsen C, Ludvigsen M. Enemark MH, et al. Among authors: plesner tl. Blood Cancer J. 2024 Sep 30;14(1):167. doi: 10.1038/s41408-024-01150-3. Blood Cancer J. 2024. PMID: 39349431 Free PMC article. No abstract available.
The role of trephine bone marrow biopsies in the era of measurable residual disease-Results from the CLL10 trial of the German CLL Study Group (GCLLSG).
Kutsch N, Robrecht S, Fink A, Lange E, Weide R, Kiehl MG, Sökler M, Schlag R, Vehling-Kaiser U, Köchling G, Plöger C, Gregor M, Plesner T, Clausen MR, Oschlies I, Ritgen M, Herling M, Fischer K, Döhner H, Wendtner CM, Kreuzer KA, Stilgenbauer S, Hallek M, Böttcher S, Klapper W, Eichhorst B. Kutsch N, et al. Among authors: plesner t. Hemasphere. 2024 Jul 24;8(7):e126. doi: 10.1002/hem3.126. eCollection 2024 Jul. Hemasphere. 2024. PMID: 39050548 Free PMC article. No abstract available.
Co-shared genomic alterations within tumors from patients with both myeloproliferative neoplasms and lymphoma.
Holst JM, Pedersen MB, Enemark MB, Hansen MC, Noerhave PR, Plesner TL, Frederiksen H, Moeller MB, Hamilton-Dutoit SJ, Noergaard P, Mortensen BK, Ommen HB, Stentoft J, Tam W, Ludvigsen M, Chan WC, Birkbak NJ, Inghirami G, D'Amore F. Holst JM, et al. Among authors: plesner tl. Haematologica. 2024 Dec 1;109(12):4067-4072. doi: 10.3324/haematol.2023.283798. Haematologica. 2024. PMID: 39049601 Free PMC article. No abstract available.
181 results